CUSIP 04272N102COMAVBPQ4 2025
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradeQ4 2025
120 funds hold this security · Q4 2025
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Infinitum Asset Management, LLC | 4.12M | $82.97M | +255.0K | Added |
| 2 | Suvretta Capital Management, LLC | 4.11M | $82.61M | +402.6K | Added |
| 3 | Hhlr Advisors, Ltd. | 3.93M | $79.05M | −555.6K | Reduced |
| 4 | Fmr LLC | 3.70M | $74.52M |
| +296.0K |
| Added |
| 5 | Orbimed Advisors LLC | 3.03M | $60.91M | 0 | Held |
| 6 | Blackrock, Inc. | 2.37M | $47.74M | +326.7K | Added |
| 7 | Octagon Capital Advisors LP | 1.97M | $39.66M | 0 | Held |
| 8 | Novo Holdings A/S | 1.94M | $39.08M | 0 | Held |
| 9 | Vanguard Group Inc | 1.87M | $37.61M | −160.3K | Reduced |
| 10 | Sofinnova Investments, Inc. | 1.70M | $34.14M | 0 | Held |
See every fund holding Arrivent Biopharma Inc, with full quarter-over-quarter share changes.
Unlock all holders